1[1] Hay ID,Grant CS,Van Heerden JA,et al.Papillary thyroid microcarcinoma:a study of 535 cases observed in a 50-year period.Surgery,1992,112(6)∶1139-1146
2[2] Noguchi S，Yamashita H,Murakami N,et al.Small carcinoma of the-thyroid.Arch Surg,1996,131(12)∶187-194
3[3] Salvadors B,Del Bo R,Pilottis,et al.“Occult” carcinoma of the thyroid:a questionable eufity,Eur J Cancer,1993,29A(13)∶1817-1825
4[12]Lazarus JH, Obuobie K. Thyroid disorder-an update. Postgrad Med J, 2000, 76(899): 529
5[13]Quadro L, Panariello L, Salvatore D, et al. Frequent RET proto-oncogene mutations in multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab, 1994, 79(2): 590
6[14]Bongarzone I, Pierotti MA, Monzini N,et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene, 1989, 4(12): 1457
7[15]Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med, 2002, 43(9): 1188
8[1]Mishra A, Agarwal A, Agarwal G, et al. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg, 2001, 25(3): 307
9[2]Gimm O, Brauckhoff M, Thanh PN, et al. An update of thyroid surgery. Eur J Nucl Med, 2002, 29(supple 2): s447
10[3]Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 1994, 97(5): 418
1Tollin S T.The use of fine-needle aspiration.biopsy under ultraound guidance to assess the risk of malignancy in patients with a multinodular goiter[J].Thyroid,2000,10:235
2Tollin ST.The use of fine-needle aspiration.biopsy underultraound guidance to assess the risk of malignancy in patients with a multinodular goiter[J].Thyroid,2000,10:235.
